Fixed airflow obstruction among nonsmokers with asthma: A case-comparison study

Journal of Asthma

Volumn 50, Issue 6, 2013, Pages 606-612

  Sexton, Paul ^a   Black, Peter ^a   Wu, Lian ^a   Sommerville, Fay ^a   Hamed, Maye ^b   Metcalf, Patricia ^a   Kolbe, John ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Asthma; Chronic bronchitis; Chronic obstructive pulmonary disease; Cross sectional studies; Etiology

Indexed keywords

NITRIC OXIDE; TOBACCO SMOKE;

ADULT; AGED; AIRWAY OBSTRUCTION; ALLERGY; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DISEASE DURATION; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE HOMEOSTASIS; HUMAN; INDOOR AIR POLLUTION; INFLAMMATION; INSULIN RESISTANCE; INTERVIEW; LUNG FUNCTION; MALE; METABOLIC SYNDROME X; OBESITY; OUTPATIENT CARE; PHLEBOTOMY; PRICK TEST; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; SPIROMETRY; SPUTUM;

AIRWAY OBSTRUCTION; ASTHMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE; OBESITY; RESPIRATORY TRACT INFECTIONS; SPIROMETRY; TOBACCO SMOKE POLLUTION;

EID: 84880567110     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.793706     Document Type: Article

References (58)

1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355(21):2226-2235
2. Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NHT, Timens W, Postma DS. Lung function decline in asthma: Association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61(2):105-110
3. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150(3):629-634
4. de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, Leynaert B, Sunyer J, Svanes C, Wjst M, Burney P, the European Community Respiratory Health Survey (ECRHS). Risk factors for Chronic Obstructive Pulmonary Disease in a European cohort of young adults. Am J Respir Crit Care Med 2011; 183:891-897
5. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR, Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182(5):693-718
6. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA, the BOLD Collaborative Research Group. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 2011; 139(4):752-763
7. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009; 374(9691):733-743
8. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G. American thoracic society statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167(5):787-797
9. Po JYT, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: Systematic review and meta-analysis. Thorax 2011; 66(3):232-239
10. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2011 [cited; Available from: http://www.goldcopd.org
11. ten Brinke A. Risk factors associated with irreversible airflow limitation in asthma. Curr Opin Allergy Clin Immunol 2008; 8:63-69
12. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32(4):962-969
13. Black P, Larsen F, Ritchie S, Picton T, Wilsher M. Cardiovascular risk factors are increased in patients with severe asthma. Am J Respir Crit Care Med 2004; 169:A356
14. Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA, Jr. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes care 2004; 27(10):2478-2484
15. Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M. Nonreversible airway obstruction in never smokers: Results from the Austrian BOLD study. Respir Med 2008; 102(12):1833-1838
16. Watz H, WaschkiB, Kirsten A, Muller KC, KretschmarG, Meyer T, Holz O, Magnussen H. The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136(4):1039-1046
17. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: Findings from the British Women's Heart and Health Study. Diabetologia 2004; 47(2):195-203
18. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948-968
19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U. S. population. AmJ Respir Crit Care Med 1999; 159(1):179-187
20. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide definition. Lancet 2005; 366(9491):1059-1062
21. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, LigabueG, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit CareMed 2003; 167(3):418-424
22. Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004; 24(1):122-128
23. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47(1):14-18
24. Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1(1):39-47
25. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010; 65(5):384-390
26. Kamfar HZ, Koshak EE, Milaat WA. Is there a role for automated eosinophil count in asthma severity assessment?. J Asthma 1999; 36 (2):153-158
27. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118(12):1364-1372
28. Gottlieb DJ, Sparrow D, O'Connor GT, Weiss ST. Skin test reactivity to common aeroallergens and decline of lung function. The Normative Aging Study. Am J Respir Crit Care Med 1996; 153 (2):561-566
29. Schayck CPV, Dompeling E, Herwaarden CLV, Wever AM, Weel CV. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144(6):1297-1301
30. Burgess JA, Matheson MC, Gurrin LC, Byrnes GB, Adams KS, Wharton CL, Giles GG, Jenkins MA, Hopper JL, Abramson MJ, Walters EH, Dharmage SC. Factors influencing asthma remission: a longitudinal study from childhood to middle age. Thorax 2011; 66(6):508-513
31. Connolly CK, Chan NS, Prescott RJ. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Postgrad Med J 1988; 64(752):422-425
32. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, Dweik RA, Fitzpatrick AM, Gaston B, Hew M, Hussain I, Jarjour NN, Israel E, Levy BD, Murphy JR, Peters SP, Teague WG, Meyers DA, Busse WW, Wenzel SE, National Heart LBIsSARP. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119(2):405-413
33. Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113(1):101-108
34. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: A longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002; 165(11):1480-1488
35. de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, Corsico A, Gislason D, Gulsvik A, Jõgi R, Martínez- Moratalla J, Pin I, Janson C, Group ECRHST. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol 2007; 119(3):611-617
36. O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen Y-Z, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA, Group STARTI. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006; 129(6):1478-1485
37. Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma?. Thorax 2003; 58(2):163-174
38. Tang MLK, Wilson JW, Stewart AG, Royce SG. Airway remodelling in asthma: Current understanding and implications for future therapies. Pharmacol Ther 2006; 112(2):474-488
39. Ward C, Walters H. Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol 2005; 5(1):43-48
40. Bonacci JV, Harris T, Wilson JW, Stewart AG. Collagen-induced resistance to glucocorticoid anti-mitogenic actions:Apotential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway. Br J Pharmacol 2003; 138(7):1203-1206
41. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3):356-359
42. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: 'Cause or effect'?. Curr Diabetes Rev 2006; 2(2):195-211
43. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142:86-93
44. Sukkar MB, Wood LG, Tooze M, Simpson JL, McDonald VM, Gibson PG, Wark PAB. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J 2012; 39(3):721-729
45. Fuso L, Pitocco D, Longobardi A, Zaccardi F, Contu C, Pozzuto C, Basso S, Varone F, Ghirlanda G, Incalzi RA. Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus. Diabetes Metab Res Rev 2012; 28:370-275
46. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE, Selvin E, Brancati FL. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31(4):741-746
47. Goksör E, Åmark M, Alm B, Gustafsson PM, Wennergren G. The impact of pre-and post-natal smoke exposure on future asthma and bronchial hyper-responsiveness. Acta Paediatrica 2007; 96:1030-1035
48. Hasselgren M, Arne M, Lindahl A, Janson S, Lundbäck B. Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care 2001; 19(1):54-57
49. Mannino DM. GOLD stage 0 COPD: Is it real?. Does it matter?. Chest 2006; 130(2):309-310
50. Brito-Mutunayagam R, Appleton SL, Wilson DH, Ruffin RE, Adams RJ, Team NWACHS. Global Initiative for Chronic Obstructive Lung Disease stage 0 is associated with excess FEV (1) decline in a representative population sample. Chest 2010; 138(3):605-613
51. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58(8):659-664
52. Perng D-W, Huang H-Y, Chen H-M, Lee Y-C, Perng R-P. Characteristics of airway inflammation and bronchodilator reversibility in COPD: A potential guide to treatment. Chest 2004; 126(2):375-381
53. Melosini L, Dente FL, Bacci E, Bartoli ML, Cianchetti S, Costa F, Franco AD, Malagrinò L, Novelli F, Vagaggini B, Paggiaro P. Asthma control test (ACT): Comparison with clinical, functional, and biological markers of asthma control. J Asthma 2012; 49(3):317-323
54. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31(1):143-178
55. TaiASN, TranH, RobertsM, ClarkeN, WilsonJW, RobertsonCF. Pediatric origins of adult chronic obstructive pulmonary disease (COPD): Childhood asthma. Am J Respir Crit Care Med 2010; 181:A2275
56. Finucane KE, Greville HW, Brown PJ. Irreversible airflow obstruction. Evolution in asthma. Med J Aust 1985; 142(11):602-604
57. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: Insights from the TENOR study. Chest 2007; 132(6):1882-1889
58. Eckel RH, Alberti K, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet 2010; 375(9710):181-183